A pharmacogenetic-driven approach for controlled ovarian hyperstimulation by FSH treatment

Minerva Ginecologica

Volumn 66, Issue 6, 2014, Pages 543-549

  Colognato, R ^a,c   Aiello, R ^b   Dulcetti, F ^c   Ruggeri, A M ^c   De Toffol, S ^c   Marcato, L ^c   Irollo, A M ^b   Criscuolo, C ^b   Gangale, M F ^b   Maggi, F ^c   Simoni, G ^c  

^a GeXNano srl   (Italy)

^b Clinica Chianciano Salute   (Italy)

^c TOMA Advanced Biomedical Assays SpA   (Italy)

Author keywords

Fertilization in vitro; Ovarian follicle; Polymorphisms, single nucleotide

Indexed keywords

FOLLITROPIN RECEPTOR; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; UROFOLLITROPIN; FOLLITROPIN;

ADULT; ARTICLE; CONTROLLED OVARIAN HYPERSTIMULATION; FEMALE; FERTILIZATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PHARMACOGENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE; COMPARATIVE STUDY; DOSE RESPONSE; FERTILIZATION IN VITRO; GENETICS; METABOLISM; OVULATION INDUCTION; PROCEDURES; TREATMENT OUTCOME;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GENOTYPE; HUMANS; OOCYTES; OVARIAN FOLLICLE; OVULATION INDUCTION; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, FSH; TREATMENT OUTCOME;

EID: 84923820369     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Laan M, Grigorova M, Huhtaniemi IT. Pharmacogenetics of follicle-stimulating hormone action. Curr Opin Endocrinol Diabetes Obes 2012;19:220-7.
2. Loutradis D, Theofanakis Ch, Anagnostou E, Mavro-gianm D, Partsinevelos GA. Genetic profile of SNP(s) and ovulation induction. Curr Pharm Biotechnol 2012;13:417-25
3. Altmae S, Hovatta O, Stavreus-Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimu-lation where do we stand today? Hum Reprod Update 2011;17:813-28
4. Luotradis D, Vlismns A, Drakakis P, Antsaklis A. Pharmacogenetics in ovarian stimulation - Current concepts. Ann NY Acad Sci 2008;1127:10-9
5. de Castro F, Morón FJ. Montoro L, Galán JJ, Hernández DP, Padilla ES et al. Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics 2004;14:285-93.
6. Matorras R, Osuna C, Exposito A, Crisol L, Pijoan JI. Recombinant FSH versus highly purified FSH in intrauterine insemination systematic review and metaanalysis. Fertil Steril 2011;95:1937-42
7. Pacchiarotti A, Sbracia M, Frega A, Selman H, Rinaldi L. Pacchiarotti A. Urinary hMG (Meropur) versus recombinant FSH plus recombinant LH (Pergovens) in IVF: a multicenter, prospective, randomized controlled trial. Fertil Steril 2010;94 2467-9
8. Layman LC, Lee EJ. Peak DB, Namnoum AB. Vu KY. van Lingen BL et al. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subumt gene. N Engl J Med 1997;337:607-11
9. Lavman LC, Porto AL, Xie J, da Motta LA, da Motta LD, Weiser W et al. FSH beta gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia. J Clin Endocrinol Metab 2002;87:3702-7
10. Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G et al. Primary amenorrhoea and infertility due to a mutation in the beta-subumt of follicle-stimulating hormone. Nat Genet 1993;5:83-6
11. Phillip M, Arbelle JE, Segev Y, Parvan R. Male hypogonadism due to a mutation in the gene for the beta-subumt of follicle-stimulating hormone. N Engl J Med 1998;338:1729-32
12. Aittomaki K, Lucena JL, Pakannen P. Sistonen P, Ta-panainen J, Gromoll J et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ov arian failure. Cell 1995;82:959-68
13. Beau I, Touraine P, Medun G, Gougeon A, Desroches A, Matuchansky C et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest 1998;102:1352-9
14. Doherty E, Pakarinen P, Tiitinen A, Kulavuori A, Huhtaniemi I, Forrest S et al. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocrinol Metab 2002;87:1151-5
15. Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, Vacher-Lavenu MC et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor clinical, histological, and molecular studies. J Clin Endocrinol Metab 2003;88:3491-8.
16. Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C et al. New natural inactivating mutations of the follicle-stimulating hormone receptor correlations between receptor function and phenotype. Mol Endocrinol 1999;13:1844-54
17. Allen LA, Achermann JC. Pakarinen P, Kotlar TJ, Huhtaniemi IT, Jameson JL et al. A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonad-ism clinical and molecular characteristics. Hum Reprod 2003;18:251-6.
18. Kuechler A, Hauffa BP, Koninger A, Kleinau G, Albrecht B, Horsthemke B et al. An unbalanced translocation unmasks a recessive mutation in the follicle-stimulating hormone receptor (FSHR) gene and causes FSH resistance. Eur J Hum Genet 2010;18:656-61
19. Rannikko A, Pakarinen P, Manna PR, Beau I, Misrahi M, Aittomaki K et al. Functional characterization of the human FSH receptor with an inactivating Al-al89Val mutation. Mol Hum Reprod 2002;8:311-7
20. Tranchant T, Durand G. Gauthier C, Crépieux P, Ul-loa-Aguirre A, Royère D et al. Preferential b-arrestm signalling at low receptor density revealed by functional characterization of the human FSH receptor A189 V mutation. Mol Cell Endocrinol 2011;331:109-18.
21. Behre HM, Greb RR, Mempel A, Sonntag B, Kie-sel L, Kaltwasser P et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Phar-macogenet Genomics 2005;15:451-6
22. Greb RR, Grieshaber K, Gromoll J. Sonntag B, Nie-schlag E, Kiesel L, Simoni M. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 2005;90:4866-72
23. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 2002;8:893-9.
24. Laven JS, Mulders AG, Suryandari DA, Gromoll J, Nieschlag E, Fauser BC et al. Follicle-stimulating hormone receptor polymorphisms in women with nor-mogonadotropic anovulatory infertility. Fertil Stenl 2003;80:986-92
25. Conway GS, Conway E, Walker C, Hoppner W, Gromoll J, Simoni M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol (Oxf) 1999;51:97-9
26. Sundblad V, Chiauzzi VA, Escobar ME, Dain L, Char-reau EH. Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF). Mol Cell Endocrinol 2004;222:53-9
27. Binder H, Dittnch R, Hager I, Muller A, Oeser S, Beckmann MW et al. Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome. Reproduction 2008;135:107-16
28. Anagnostou E, Mavrogranni D, Theofanakis Ch, Drakakis P, Bletsa R, Dermrol A et al. ESR1, ESR2 and FSH receptor gene polymorphisms in combination a useful genetic tool for the prediction of poor responders. Curr Pharm Biotechnol 2012;13:426-34.
29. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSII) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000;85:3365-9
30. de Castro F, Ruiz R, Montoro L, Perez-Hernandez D, Sanchez-Casas Padilla E, Real L et al. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacv of follicle-stimulating hormone. Fertil Steril 2003;80:571-6
31. Falconer H, Andersson E, Aanesen A, Fried G. Follicle-stimulating hormone receptor polymorphisms in a population of infertile women. Acta Obstet Gynecol Scand 2005;84:806-11
32. Lalioti MD. Impact of follicle stimulating hormone receptor variants in fertility. Curr Opin Obstet Gynecol 2011;23:158-67
33. Lazaros LA, Hatzi FG, Pamporaki CE, Sakaloglou PI, Xita NV, Markoula SI et al. The ovarian response to standard gonadotrophs stimulation depends on FSHR, SHBG and CYP19 gene synergism. J Assist Reprod Genet 2012;29:1185-91
34. Morón FJ. Ruiz A. Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSFI receptor genetic markers. Phar-macogenomics 2010;11:1613-8
35. Huhtaniemi IT, Themmen AP. Mutations in human gonadotropin and gonado-tropin-receptor genes. Endocrine 2005;26:207-17
36. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Pa-pachristou DJ et al. FSFI directly regulates bone mass. Cell 2006;125:247-60